作者
John D Brunzell, Michael Davidson, Curt D Furberg, Ronald B Goldberg, Barbara V Howard, James H Stein, Joseph L Witztum
发表日期
2008/4/15
来源
Journal of the American College of Cardiology
卷号
51
期号
15
页码范围
1512-1524
出版商
American College of Cardiology Foundation
简介
Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster, including obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and hypertension. These conditions can also occur in isolation, and they are exaggerated by physical inactivity and smoking. Since each of these factors increases risk of CVD, the concept of global cardiometabolic risk (CMR)(Fig. 1) is of value (1). Lipoprotein abnormalities, including elevated triglycerides, low HDL cholesterol, and increased numbers of small dense LDL particles, are common findings in patients with CMR. Clinical entities with increased CMR include type 2 diabetes, familial combined hyperlipidemia, familial hypoalphalipoproteinemia, and polycystic ovary syndrome (2). These disorders often share the CMR characteristics of central obesity, insulin resistance, dyslipoproteinemia, and hypertension.
There are stringent lipid …
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024443117124158140138133113869371664855453520